Dr Joshua Windmiller, CEO
Nov 19, 2014.
Santa Clara 2014 Presentation - Electrozyme LLC*
Santa Clara 2014 Audio Presentation - Electrozyme LLC*
If you already have access, please [Login]
Access is available via an IDTechEx Market Intelligence Subscription
Printed epidermal biosensors for non-invasive metabolite monitoring: Skin-applied biosensors for real-time assessment of small molecules excreted in the perspiration
Printed epidermal biosensors for non-invasive electrolyte monitoring: Skin-applied biosensors for real-time assessment of electrolyte loss and balance in the perspiration
Printed epidermal power sources: Development of skin-applied biofuel cells for system integration
Speaker Biography (Joshua Windmiller)
Dr. Joshua Windmiller is an internationally-recognized expert in wearable electrochemical biosensor technology. His Ph.D. research, funded by a Powell Foundation fellowship, focused on the development of printed biosensors, bioelectronics, and biofuel cells. He has published over 50 manuscripts in peer-reviewed journals and conference proceedings and has eleven US patents issued or pending. Dr. Windmiller, a Gordon Fellow, NIH SHIFT awardee, and two-time NIH Lab-to-Marketplace awardee is the recipient of the Printed Electronics USA 2010 Academic R&D award for his developments in textile-based printed bioelectronics. He completed a postdoctoral fellowship in the Laboratory for NanoBioElectronics at UCSD in 2013, where he was supported by the von Liebig Center for Entrepreneurism and led a commercialization grant sponsored by the DOE. For his successful product development activities leading to the commercialization of novel printed bioelectronic paradigms, he received the Printed Electronics USA 2014 Product Development award. He currently serves as the CTO of Biolinq, a startup that he co-founded devoted to the development of the novel biosensing modalities he has invented for application in the personal wellness and healthcare domains.
Company Profile (Electrozyme LLC)
View Electrozyme LLC Timeline
Seeking to capitalize on the emerging field of wearable devices, Electrozyme endeavors to become the world leader in the development of epidermal sensor technology. The Company leverages its proprietary insights into advanced electrochemical transduction techniques, non-invasive biomarker quantification, and thick-film fabrication technology. Electrozyme, located in La Jolla, CA, is currently engaged in several co-development efforts with strategic partners in the sports, fitness, healthcare, beautycare, and consumer electronics domains.